Spitomin

Medicinal product

(Invented) name

Spitomin

Active substance (s)

Buspironas

Strength

5 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N05BE01, Buspirone

Marketing authorisation holder

Egis Pharmaceuticals PLC, Vengrija

Date of authorisation

1999-10-08

Date of renewal

2010-07-02

Documents

2092 Spitomin RPP 2024 01 31.docx

2092 Pakuotės lapelis 2024 01 31.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Buspironas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
581	6508	1006508	lizdinė plokštelė	N60		Receptinis	LT/1/99/2092/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2010-07-02	Perregistruotas
1999-10-08	Registruotas